Literature DB >> 3544894

An ultrastructural study of the effects of mefloquine on malaria parasites.

G H Jacobs, M Aikawa, W K Milhous, J R Rabbege.   

Abstract

The ultrastructural changes induced by the administration of a recently developed antimalarial drug, mefloquine, were studied in mice infected with Plasmodium berghei and human erythrocytes infected with P. falciparum in vitro. Pronounced changes which occurred in both experiments comprised swelling of the parasites' food vacuoles with gradual loss of pigment granules, which did not form clumps as occurs with chloroquine. These findings suggest that the malarial parasites' food vacuole is the target of this drug.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3544894     DOI: 10.4269/ajtmh.1987.36.9

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Antimalarial agents: mechanisms of action.

Authors:  P H Schlesinger; D J Krogstad; B L Herwaldt
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

3.  Synthesis, structure-activity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds.

Authors:  Steven J Burgess; Jane X Kelly; Shawheen Shomloo; Sergio Wittlin; Reto Brun; Katherine Liebmann; David H Peyton
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

4.  Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design.

Authors:  L W Scheibel; P M Colombani; A D Hess; M Aikawa; C T Atkinson; W K Milhous
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 5.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

6.  Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum.

Authors:  Heinrich C Hoppe; Donelly A van Schalkwyk; Ursula I M Wiehart; Sandra A Meredith; Joanne Egan; Brandon W Weber
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

7.  Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure.

Authors:  Leah Mwai; Abdi Diriye; Victor Masseno; Steven Muriithi; Theresa Feltwell; Jennifer Musyoki; Jacob Lemieux; Avi Feller; Gunnar R Mair; Kevin Marsh; Chris Newbold; Alexis Nzila; Céline K Carret
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

8.  Spectrophotometric detection of susceptibility to anti-malarial drugs.

Authors:  Yulia M Serebrennikova; Janus Patel; Wilbur K Milhous; Luis H Garcia-Rubio; Debra E Huffman; Jennifer M Smith
Journal:  Malar J       Date:  2013-08-30       Impact factor: 2.979

9.  Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols.

Authors:  M Mungthin; P G Bray; R G Ridley; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.